SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 9.88
-0.38 (-3.66%)
Aug 14, 2026, 4:29 PM GMT
SkinBioTherapeutics Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 5.23 | 4.64 | 1.21 | 0.13 | 0.07 | - |
| 5.23 | 4.64 | 1.21 | 0.13 | 0.07 | - | |
Revenue Growth | 95.16% | 283.74% | 815.26% | 76.64% | - | - |
Cost of Revenue | 2.04 | 1.78 | 0.53 | 0.05 | 0.03 | - |
Gross Profit | 3.19 | 2.86 | 0.68 | 0.09 | 0.05 | - |
Selling, General & Admin | 4.11 | 3.86 | 3.03 | 2.15 | 2.17 | 0.99 |
Research & Development | 0.17 | 0.13 | 0.56 | 0.93 | 0.86 | 0.51 |
Operating Expenses | 4.28 | 3.98 | 3.59 | 3.08 | 3.03 | 1.5 |
Operating Income | -1.1 | -1.12 | -2.91 | -3 | -2.98 | -1.5 |
Interest Expense | -0.12 | -0.09 | -0.04 | -0.01 | -0.01 | -0 |
EBT Excluding Unusual Items | -1.22 | -1.22 | -2.95 | -3.01 | -2.99 | -1.5 |
Other Unusual Items | 0.75 | 0.5 | - | - | - | - |
Pretax Income | -0.47 | -0.72 | -2.95 | -3.01 | -2.99 | -1.5 |
Income Tax Expense | -0.01 | -0.02 | -0.07 | -0.17 | -0.2 | -0.07 |
Net Income | -0.46 | -0.7 | -2.88 | -2.84 | -2.79 | -1.43 |
Net Income to Common | -0.46 | -0.7 | -2.88 | -2.84 | -2.79 | -1.43 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 246 | 228 | 186 | 165 | 157 | 147 |
Shares Outstanding (Diluted) | 246 | 228 | 186 | 165 | 157 | 147 |
Shares Change | 17.39% | 22.32% | 13.10% | 5.06% | 6.87% | 14.53% |
EPS (Basic) | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.97 | -1.24 | -2.74 | -2.73 | -2.67 | -1.56 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
Gross Margin | 60.95% | 61.65% | 56.51% | 64.51% | 60.64% | - |
Operating Margin | -20.95% | -24.21% | -240.36% | -2271.26% | -3988.83% | - |
Profit Margin | -8.73% | -15.01% | -237.95% | -2146.91% | -3735.37% | - |
Free Cash Flow Margin | -37.68% | -26.76% | -226.80% | -2071.02% | -3575.44% | - |
EBITDA | -0.73 | -0.82 | -2.77 | -2.99 | -2.98 | -1.5 |
EBITDA Margin | -14.05% | -17.65% | -229.38% | - | - | - |
D&A For EBITDA | 0.36 | 0.3 | 0.13 | 0.01 | 0 | 0 |
EBIT | -1.1 | -1.12 | -2.91 | -3 | -2.98 | -1.5 |
EBIT Margin | -20.95% | -24.21% | -240.36% | - | - | - |